FluoGuide A/S (STO:FLUO)
Sweden · Delayed Price · Currency is SEK 40.20
+2.00 (5.24%)
Apr 14, 2026, 5:23 PM CET
FluoGuide Revenue
In the year 2025, FluoGuide had annual revenue of 220.00K DKK, down -42.86%. FluoGuide had revenue of 54.00K in the quarter ending December 31, 2025.
Revenue
220.00K DKK
Revenue Growth
-42.86%
P/S Ratio
1,959.09
Revenue / Employee
32.84K DKK
Employees
7
Market Cap
624.54M SEK
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 220.00K | -165.00K | -42.86% |
| Dec 31, 2024 | 385.00K | -38.00K | -8.98% |
| Dec 31, 2023 | 423.00K | -6.09M | -93.50% |
| Dec 31, 2022 | 6.51M | -3.10M | -32.27% |
| Dec 31, 2021 | 9.61M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cantargia AB | 316.70M |
| Sprint Bioscience AB | 167.17M |
| Genovis AB (publ.) | 129.65M |
| Oncopeptides AB | 71.12M |
| Bio-Works Technologies AB | 63.11M |
| Corline Biomedical AB | 8.59M |
| Xspray Pharma AB | 2.47M |
| Infant Bacterial Therapeutics AB | -1.00K |